Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by D. Cella
Reliability and meaningful change of the Patient‐Reported Outcomes Measurement Information System Itch Questionnaire® (PIQ) Item‐Banks in adults with atopic dermatitis
RESEARCH LETTER J.I. Silverberg Corresponding Author JonathanISilverberg@Gmail.com orcid.org/0000-0003-3686-7805 Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA Departments of Dermatology, Feinberg School of Medicine at, Northwestern University, Chicago, IL, USA Corresponding author Jonathan I.
一项使用儿童特应性皮炎影响量表研究分数随时间变化的研究
Summary 特应性皮炎是一种常见的皮肤病,会引起极度瘙痒(称为瘙痒症),主要影响儿童。在美国 (U.S.A.),大约 17% 的小学生被认为患有特应性皮炎,而在北欧,这一比例大约为 16%。 本研究的研究人员位于美国和德国。儿童特应性皮炎影响量表 (CADIS) 是一项问卷,用于衡量特应性皮炎年幼儿童患者及其父母的生活质量。本研究旨在探讨 CADIS 是否能够检测出随时间的流逝发生的变化,以及需要多大变化才能对患者有益。儿童患者的父母完成了 CADIS 并在初次入组时和四个星期后对其小孩的皮肤状况进行了单个问题的评分。 只有皮肤状况改善的儿童在四周后显示出显著改善的 CADIS 评分,即 CADIS 对改善的趋势变化很灵敏。但是,变化的分数必须可解读才具有临床意义。因此,作者计算了最小重要变化 (MIC),这是患者认为有益的最小分数变化。发现 CADIS 改善超过 12% 很有可能代表临床上的重要变化。由于 CADIS 能够测量一段时间内的变化,因此它是临床实践中的有用工具。 本摘要涉及研究:儿童特应性皮炎影响量表的反应性评估以及最小可检测变化和最小重要变化分数的估计
A study looking at changes in scores over time when using the Childhood Atopic Dermatitis Impact Scale
Summary Atopic dermatitis is a common skin disease that causes extreme itching (called pruritus) and which mainly affects children. In the United States (U.S.A.), around 17% of schoolchildren are thought to have experienced atopic dermatitis and in Northern Europe, it is similar at about 16%. The researchers of this study are based in the U.S.A and in Germany.
Evaluation of responsiveness and estimation of smallest detectable change and minimal important change scores for the Childhood Atopic Dermatitis Impact Scale
Background The Childhood Atopic Dermatitis Impact Scale (CADIS) is an instrument to measure quality of life in young children affected by atopic dermatitis, and their parents. Objectives To evaluate the responsiveness (sensitivity to change), smallest detectable change (SDC) and minimal important change (MIC) of the CADIS. Methods Parents and primary caregivers of 300 young children completed the CADIS and a global rating of their child's skin condition at baseline and a 4‐week follow‐up.
Quality of life (QoL) in the phase 3 METEOR trial of cabozantinib vs everolimus for advanced renal cell carcinoma (RCC)
Background: In a randomized Phase 3 trial in advanced RCC after prior VEGFR TKI therapy (Choueiri N Engl J Med 2015, ASCO 2016 abstract 4506) cabozantinib was superior to everolimus in the primary endpoint of PFS (median 7.4 vs 3.8 mo; HR 0.58; p < 0.0001) and significantly improved secondary endpoints of OS (median 21.4 vs 16.5 mo; HR 0.66; p = 0.0003) and ORR (17% vs 3%; p < 0.0001). QoL outcomes were exploratory endpoints.
PSYCHOMETRIC EVALUATION OF THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-ANEMIA (FACT-AN) IN DIALYSIS AND NON-DIALYSIS PATIENTS WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE - Value in Health
Anemia is a common complication in patients with chronic kidney disease (CKD). The Functional Assessment of Cancer Therapy-Anemia (FACT-An), which measures health-related quality of life and anemia symptoms in cancer patients, has been used as an outcome measure in CKD trials. We assessed the measurement properties of FACT-An scores in CKD-related anemia.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with D.
Contact D., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack